# China NMPA Inspection - Guangzhou Cimei Biotechnology Co., Ltd. - January 14, 2021

Source: https://www.globalkeysolutions.net/records/china_inspection/guangzhou-cimei-biotechnology-co-ltd/22f8d6f4-cfcc-4bef-9a17-c1a29abbebd3/
Source feed: China

> China NMPA unannounced inspection for Guangzhou Cimei Biotechnology Co., Ltd. published January 14, 2021. The National Medical Products Administration (NMPA) of China issued a notification on January 14, 2021, regarding an unannounced inspection of Guangzh

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Notification of unannounced inspection of Guangzhou Cimei Biotechnology Co., Ltd.
- Company Name: Guangzhou Cimei Biotechnology Co., Ltd.
- Publication Date: 2021-01-14
- Product Type: cosmetics
- Summary: The National Medical Products Administration (NMPA) of China issued a notification on January 14, 2021, regarding an unannounced inspection of Guangzhou Cimei Biotechnology Co., Ltd. This official communication, accessible on the NMPA's website, confirms regulatory oversight activity involving the company. The document establishes the NMPA as the overarching regulatory framework for this inspection. However, the provided content is limited to the announcement itself. It does not disclose the specific dates when the unannounced inspection was conducted, detail any main violations or issues discovered during the assessment, or outline any specific required actions or corrective measures mandated for Guangzhou Cimei Biotechnology Co., Ltd. The notification primarily serves as a public record of the inspection event, without offering deeper insights into its findings or the subsequent regulatory directives. Therefore, a comprehensive understanding of the inspection's outcomes or the specific compliance expectations cannot be derived from this notification alone.

Company: https://www.globalkeysolutions.net/companies/guangzhou-cimei-biotechnology-co-ltd/d9698d96-8ca7-4c74-936f-fee73834404b/